Mechanistic insights into the dual role of CCAR2/DBC1 in cancer.
- Published in:
- Experimental & Molecular Medicine EMM, 2023, v. 55, n. 8, p. 1691, doi. 10.1038/s12276-023-01058-1
- By:
- Publication type:
- Article
Works by Sue Jin Moon
Results: 5
1
2
Bruceantin targets HSP90 to overcome resistance to hormone therapy in castration-resistant prostate cancer.
- Published in:
- Theranostics, 2021, v. 11, n. 2, p. 958, doi. 10.7150/thno.51478
- By:
- Publication type:
- Article
3
DBC1 is a key positive regulator of enhancer epigenomic writers KMT2D and p300.
- Published in:
- Nucleic Acids Research, 2022, v. 50, n. 14, p. 7873, doi. 10.1093/nar/gkac585
- By:
- Publication type:
- Article
4
Sequence variants in the proximal promoter and +5.8‐kb site of ABO in Koreans with weak B phenotypes.
- Published in:
- Vox Sanguinis, 2022, v. 117, n. 3, p. 442, doi. 10.1111/vox.13207
- By:
- Publication type:
- Article
5
DBC1 regulates Wnt/β-catenin-mediated expression of MACC1, a key regulator of cancer progression, in colon cancer.
- Published in:
- Cell Death & Disease, 2018, v. 9, n. 8, p. 1, doi. 10.1038/s41419-018-0899-9
- By:
- Publication type:
- Article